Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer
Active, not recruiting · NCT05340309 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-01-29 | NCT05340309 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
| National Cancer Institute (NCI) | 3015 |
| University of Southern California | 216 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |